Members of the Department

Faculty

  • UJIIE Hideyuki
    Professor and Chair

    More

    Certification

    Board Certification by Japanese Dermatological Association

    Professional Societies

    The Japanese Dermatological Association (Delegate and Guideline Committee Member)
    The Japanese Society for Investigative Dermatology (Councilor)
    Japan Organization of Clinical Dermatologists
    Japanese Society for Immunology
    Japanese Society of Allergology (Hokkaido Branch Councilor)
    The Japanese Society for Cutaneous Immunology and Allergy
    Japanese Society for Psoriasis Research (Councilor)
    Society for Investigative Dermatology
    European Society for Dermatological Research

    Education and professional experience

    2002 Mar M.D., Hokkaido University School of Medicine
    2002 May Resident, Dermatology Dept., Hokkaido Univ. Hospital
    2005 Apr Resident, Dermatology Dept., Hokkaido Cancer Center
    2010 Mar Ph.D., Dermatology Dept., Graduate School of Medicine, Hokkaido University
    2010 Apr Assistant professor, Dermatology Dept., Hokkaido Univ. Hospital
    2012 Sep Visiting fellow, National Institutes of Health (NIH) (Ethan Shevach Lab., USA)
    2013 Apr JSPS Overseas Research Fellowship
    2014 Sep Assistant professor, Dermatology Dept., Hokkaido Univ. Hospital
    2016 Sep Associate professor, Dermatology Dept., Hokkaido Univ. Hospital
    2021 Jan Professor and chairman, Dermatology Dept., Faculty of Medicine and Graduate School of Medicine Hokkaido University

    Major Publications

    1. Muramatsu K, Zheng M, Yoshimoto N, Ito T, Ujiie I, Iwata H, Shimizu H, Ujiie H:
      Regulatory T cell subsets in bullous pemphigoid and dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid.
      J Dermatol Sci 100: 23-30, 2020.
    2. Ujiie H, Iwata H, Yamagami J, Nakama T, Aoyama Y, Ikeda S, Ishii N, Iwatsuki K, Kurosawa M, Sawamura D, Tanikawa A, Tsuruta D, Nishie W, Fujimoto W, Amagai M, Shimizu H, Committee for Guidelines for the Management of Pemphigoid Diseases (Including Epidermolysis Bullosa Acquisita):
      Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita).
      J Dermatol 46: 1102-1135, 2019.
    3. Ujiie H, Yoshimoto N, Natsuga K, Muramatsu K, Iwata H, Nishie W, Shimizu H:
      Immune reaction to type XVII collagen induces intramolecular and intermolecular epitope spreading in experimental bullous pemphigoid models.
      Front Immunol 10: 1410, 2019.
    4. Ujiie I, Ujiie H, Iwata H, Shimizu H:
      Clinical and immunological features of pemphigus relapse.
      Br J Dermatol 180: 1498-1505, 2019.
    5. Muramatsu K, Ujiie H, Kobayashi I, Nishie W, Izumi K, Ito T, Yoshimoto N, Natsuga K, Iwata H, Shimizu H:
      Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects.
      J Allergy Clin Immunol 142: 1818-1830, 2018.
    6. Ujiie H, Muramatsu K, Mushiroda T, Ozeki T, Miyoshi H, Iwata H, Nakamura A, Nomoto H, Cho KY, Sato N, Nishimura M, Ito T, Izumi K, Nishie W, Shimizu H:
      HLA-DQB1*03:01 as a biomarker for genetic susceptibility to bullous pemphigoid induced by DPP-4 inhibitors.
      J Invest Dermatol 138: 1201-1204, 2018.
    7. Sasaoka T#, Ujiie H#, Nishie W, Iwata H, Ishikawa M, Higashino H, Natsuga K, Shinkuma S, Shimizu H:
      Intravenous IgG reduces pathogenic autoantibodies, serum IL-6 levels, and disease severity in experimental bullous pemphigoid models.
      J Invest Dermatol 138: 1260-1267, 2018. # co-first author
    8. Ujiie H, Shevach EM:
      gdT cells protect liver and lung of mice from the autoimmunity induced by scurfy lymphocytes.
      J Immunol 196: 1517-1528, 2016.
    9. Ujiie H, Sasaoka T, Izumi K, Nishie W, Shinkuma S, Natsuga K, Nakamura H, Shibaki A, Shimizu H:
      Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.
      J Immunol 193: 4415-4428, 2014.
    10. Ujiie H, Shibaki A, Nishie W, Sawamura D, Wang G, Tateishi Y, Li Q, Moriuchi R, Qiao H, Nakamura H, Akiyama M, Shimizu H:
      A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen.
      J Immunol 184: 2166-2174, 2010.

    Publication Lists (PubMed)

  • NATSUGA Ken
    Senior Associate Professor

    More

    Certification

    Ph.D., Hokkaido University Graduate School of Medicine, Japan (2010)
    Board Certification by Japanese Dermatological Association (2008)
    M.D., Hokkaido University School of Medicine, Japan (2003)

    Professional Societies

    The Japanese Dermatological Association
    The Japanese Society for Investigative Dermatology (Junior Board Director)
    Japan Organization of Clinical Dermatologists
    European Society for Dermatological Research
    Society for Investigative Dermatology
    Japan Skin Research Club (Organizer)

    Education and professional experience

    2003 Mar M.D., Hokkaido University School of Medicine
    2003 Mar Resident, Dermatology Dept., Hokkaido Univ. Hospital
    2005 Apr Resident, Dermatology Dept., Hokkaido Cancer Center
    2006 Apr Medical staff, Dermatology Dept., Hokkaido Univ. Hospital
    2010 Mar Ph.D., Dermatology Dept., Graduate School of Medicine, Hokkaido University
    2010 Sep Visiting Scientist, Cancer Research UK Cambridge Research Institute (Fiona Watt Lab., UK)
    2011 Apr JSPS Overseas Research Fellowship
    2012 Sep Assistant professor, Dermatology Dept., Graduate School of Medicine, Hokkaido University
    2016 Aug Associate professor, Dermatology Dept., Graduate School of Medicine, Hokkaido University
    2021 Feb Senior associate professor, Dermatology Dept., Faculty of Medicine and Graduate School of Medicine Hokkaido University
    2021 Apr Senior associate professor, Research Institute for Electronic Science, Hokkaido University

    Major Publications

    1. Natsuga K, Furuta Y, Takashima S, Nohara S, Kosumi H, Mai Y, Higashi H, Ujiie H:
      Detection of revertant mosaicism in epidermolysis bullosa through Cas9-targeted long read sequencing.
      Hum Mutat 43: 529-536, 2022.
    2. Wang Y, Kitahata H, Kosumi H, Watanabe M, Fujimura Y, Takashima S, Osada SI, Hirose T, Nishie W, Nagayama M, Shimizu H, Natsuga K:
      Collagen XVII deficiency alters epidermal patterning.
      Lab Invest 102: 581-588, 2022.
    3. Kosumi H, Watanabe M, Shinkuma S, Fujimura Y, Tsukiyama T, Donati G, Iwata H, Ujiie H, Natsuga K:
      Wnt/beta-catenin signaling stabilizes hemidesmosomes in keratinocytes.
      J Invest Dermatol 142: 1576-1586, 2022.
    4. Fujimura Y, Watanabe M, Ohno K, Kobayashi Y, Takashima S, Nakamura H, Kosumi H, Wang Y, Mai Y, Lauria A, Proserpio V, Ujiie H, Iwata H, Nishie W, Nagayama M, Oliviero S, Donati G, Shimizu H, Natsuga K:
      Hair follicle stem cell progeny heal blisters while pausing skin development.
      EMBO Rep 22: e50882, 2021.
    5. Watanabe M, Natsuga K, Nishie W, Kobayashi Y, Donati G, Suzuki S, Fujimura Y, Ujiie H, Shinkuma S, Nakamura H, Murakami M, Ozaki M, Nagayama M, Watt FM, Shimizu H:
      Type XVII collagen coordinates proliferation in the interfollicular epidermis.
      Elife 6: e26635, 2017.
    6. Natsuga K, Cipolat S, Watt FM:
      Increased bacterial load and expression of antimicrobial peptides in skin of barrier-deficient mice with reduced cancer susceptibility.
      J Invest Dermatol 136: 99-106, 2016.
    7. Natsuga K, Nishie W, Shinkuma S, Ujiie H, Nishimura M, Sawamura D, Shimizu H:
      Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner.
      J Immunol 188: 5792-5799, 2012.
    8. Natsuga K, Nishie W, Smith BJ, Shinkuma S, Smith TA, Parry DA, Oiso N, Kawada A, Yoneda K, Akiyama M, Shimizu H:
      Consequences of two different amino-acid substitutions at the same codon in KRT14 endicate definitive roles of structural distortion in epidermolysis bullosa simplex pathogenesis.
      J Invest Dermatol 131: 1869-1876, 2011.
    9. Natsuga K, Nishie W, Akiyama M, Nakamura H, Shinkuma S, McMillan JR, Nagasaki A, Has C, Ouchi T, Ishiko A, Hirako Y, Owaribe K, Sawamura D, Bruckner-Tuderman L, Shimizu H:
      Plectin expression patterns determine two distinct subtypes of epidermolysis bullosa simplex.
      Hum Mutat 31: 308-316, 2010.
    10. Natsuga K, Akiyama M, Shimizu T, Suzuki T, Ito S, Tomita Y, Tanaka J, Shimizu H:
      Ultrastructural features of trafficking defects are pronounced in melanocytic nevus in Hermansky-Pudlak syndrome type 1.
      J Invest Dermatol 125: 154-158, 2005.

    Publication Lists (PubMed)

  • YANAGI Teruki
    Associate professor

    More

    Certification

    Board Certification by Japanese Dermatological Association

    Professional Societies

    The Japanese Dermatological Association
    The Japanese Society for Investigative Dermatology (Councilor)
    Japanese Cancer Association

    Education and professional experience

    2003 Mar M.D., Hokkaido University School of Medicine
    2003 May Resident, Dermatology Dept., Hokkaido Univ. Hospital
    2005 Apr Medical staff, Dermatology Dept., Tonan Hospital
    2006 Apr Resident, Dermatology Dept., Hokkaido Cancer Center
    2010 Mar Ph.D., Dermatology Dept., Graduate School of Medicine, Hokkaido University
    2011 Apr JSPS Research Fellowship for Young Scientists
    2013 Apr JSPS Overseas Research Fellowship
    Sanford-Burnham Medical Research Institute (John C. Reed lab., USA)
    2015 Apr Medical staff, Dermatology Dept., Hokkaido Univ. Hospital
    2016 Apr Specially appointed Assistant professor, Dermatology Dept., Faculty of Medicine and Graduate School of Medicine Hokkaido University
    2019 Apr Assistant professor, Dermatology Dept., Hokkaido Univ. Hospital
    2021 Apr Associate professor, Dermatology Dept., Hokkaido Univ. Hospital

    Major Publications

    1. Maeda T, Kitamura S, Nishihara H, Yanagi T:
      Extramammary Paget’s disease patient-derived xenografts harboring ERBB2 S310F mutation show sensitivity to HER2-targeted therapies.
      Oncogene 39: 5867-5875, 2020.
    2. Maeda T, Kitamura S, Yanagi T:
      RANK-RANKL signaling pathway contributes to disease progression in cutaneous angiosarcoma: A case report with an immunohistochemical review and in vitro experiments.
      J Eur Acad Dermatol Venereol 34: e834-e837, 2020.
    3. Yanagi T, Kitamura S, Imafuku K, Suto A, Maeda T, Tanaka S, Sesaki H, Abe R, Shimizu H:
      Loss of dynamin-related protein 1 (Drp1) does not affect epidermal development or UVB-induced apoptosis but does accelerate UVB-induced carcinogenesis.
      J Dermatol Sci 99: 109-118, 2020.
    4. Yanagi T, Watanabe M, Hata H, Kitamura S, Imafuku K, Yanagi H, Homma A, Wang L, Takahashi H, Shimizu H, Hatakeyama S:
      Loss of TRIM29 alters keratin distribution to promote cell invasion in squamous cell carcinoma.
      Cancer Res 78: 6795-6806, 2018.
    5. Yanagi T, Hata H, Mizuno E, Kitamura S, Imafuku K, Nakazato S, Wang L, Nishihara H, Tanaka S, Shimizu H:
      PCTAIRE1/CDK16/PCTK1 is overexpressed in cutaneous squamous cell carcinoma and regulates p27 stability and cell cycle.
      J Dermatol Sci 86: 149-157, 2017.
    6. Yanagi T, Tachikawa K, Wilkie-Grantham R, Hishiki A, Nagai K, Toyonaga E, Chivukula P, Matsuzawa SI:
      Lipid nanoparticle-mediated siRNA transfer Against PCTAIRE1/PCTK1/Cdk16 inhibits in vivo cancer growth.
      Mol Ther Nucleic Acids 5: e327, 2016.
    7. Yanagi T, Krajewska M, Matsuzawa S, Reed JC:
      PCTAIRE1 phosphorylates p27 and regulates mitosis in cancer cells.
      Cancer Res 74; 5795-5807, 2014.
    8. Yanagi T, Akiyama M, Nishihara H, Ishikawa J, Sakai K, Miyamura Y, Naoe A, Kitahara T, Tanaka S, Shimizu H:
      Self-improvement of keratinocyte differentiation defects during skin maturation in ABCA12 deficient harlequin ichthyosis model mice.
      Am J Pathol 177: 106-118, 2010.
    9. Yanagi T, Akiyama M, Sakai K, Nagasaki A, Ozawa N, Kosaki R, Sago H, Shimizu H:
      DNA-based prenatal exclusion of harlequin ichthyosis.
      J Am Acad Dermatol 58: 653-656, 2008.
    10. Yanagi T, Akiyama M, Nishihara H, Sakai K, Nishie W, Tanaka S, Shimizu H.
      Harlequin ichthyosis model mouse reveals alveolar collapse and severe fetal skin barrier defects.
      Hum Mol Genet 17: 3075-3083, 2008.

    Publication Lists (PubMed)

  • IZUMI Kentaro
    Associate professor

    More

    Certification

    Board Certification by Japanese Dermatological Association

    Society

    The Japanese Dermatological Association
    The Japanese Society for Investigative Dermatology

    Education and professional experience

    2006 Mar M.D., Asahikawa Medical University School of Medicine
    2006 Apr Junior Resident, Sapporo Higashi Tokushukai Hospital
    2008 Apr Senior Resident, Dermatology Dept., Hokkaido Univ. Hospital
    2010 Apr Medical staff, Dermatology Dept., Kushiro City Hospital
    2011 Apr Medical staff, Dermatology Dept., Hakodate Central General Hospital
    2011 Jul Medical staff, Dermatology Dept., Hokkaido Univ. Hospital
    2012 Mar Ph.D., Dermatology Dept., Graduate School of Medicine, Hokkaido University
    2016 Oct Medical staff, Dermatology Dept., Hokkaido Univ. Hospital
    2017 Oct Visiting scientist, University of Lübeck (Detlef Zillikens Lab., Germany)
    2020 Jan Assistant Professor, Dermatology Dept., Faculty of Medicine and Graduate School of Medicine Hokkaido University
    2022 Apr Associate professor, Dermatology Dept., Hokkaido Univ. Hospital

    Major Publications

    1. Hayashi M, Tsunoda T, Sato F, Yaguchi Y, Igarashi M, Izumi K, Nishie W, Ishii N, Okamura K, Suzuki T, Hashimoto T:
      Clinical and immunological characterisation of 14 cases of dipeptidyl peptidase 4 inhibitor-associated bullous pemphigoid: a single centre study.
      Br J Dermatol 182: 806-807, 2020.
    2. Izumi K, Nishie W, Beniko M, Shimizu H:
      A Cross-Sectional Study Comparing the Prevalence of Bullous Pemphigoid Autoantibodies in 275 Cases of Type II Diabetes Mellitus Treated With or Without Dipeptidyl Peptidase-IV Inhibitors.
      Front Immunol 10: 1439, 2019.
    3. Izumi K, Bieber K, Ludwig RJ:
      Current Clinical Trials in Pemphigus and Pemphigoid.
      Front Immunol 10: 978, 2019.
    4. Tuusa J, Lindgren O, Tertsunen HM, Nishie W, Kokkonen N, Huilaja L, Izumi K, Herukka SK, Miettunen J, Shimizu H, Remes AM, Tasanen K:
      BP180 Autoantibodies Target Different Epitopes in Multiple Sclerosis or Alzheimer’s Disease than in Bullous Pemphigoid.
      J Invest Dermatol 139: 293-299, 2019.
    5. Mai Y, Nishie W, Sato K, Hotta M, Izumi K, Ito K, Hosokawa K, Shimizu H:
      Bullous Pemphigoid Triggered by Thermal Burn Under Medication With a Dipeptidyl Peptidase-IV Inhibitor: A Case Report and Review of the Literature.
      Front Immunol 9: 542, 2018.
    6. Izumi K , Nishie W, Mai Y, Ujiie H, Iwata H, Natsuga K, Shimizu H:
      Detection of mucous membrane pemphigoid autoantibodies by full-length BP180 enzyme-linked immunosorbent assay.
      J Dermatol Sci 88: 247-248, 2017.
    7. Toyonaga E, Nishie W, Izumi K, Natsuga K, Ujiie H, Iwata H, Yamagami J, Hirako Y, Sawamura D, Fujimoto W, Shimizu H:
      C-Terminal Processing of Collagen XVII Induces Neoepitopes for Linear IgA Dermatosis Autoantibodies.
      J Invest Dermatol 137: 2552-2559, 2017.
    8. Izumi K, Nishie W, Mai Y, Wada M, Natsuga K, Ujiie H, Iwata H, Yamagami J, Shimizu H:
      Autoantibody profile differentiates between inflammatory and non-inflammatory bullous pemphigoid.
      J Invest Dermatol 136: 2201-2210, 2016.
    9. Wada M, Nishie W, Ujiie H, Izumi K, Iwata H, Natsuga K, Nakamura H, Kitagawa Y, Shimizu H:
      Epitope-dependent pathogenicity of Abs targeting a major bullous pemphigoid autoAg collagen XVII/BP180.
      J Invest Dermatol 136: 938-946, 2016.
    10. Nishie W, Natsuga K, Iwata H, Izumi K, Ujiie H, Toyonaga E, Hata H, Nakamura H, Shimizu H:
      Context-Dependent Regulation of Collagen XVII Ectodomain Shedding in Skin.
      Am J Pathol 185: 1361-1371, 2015.

    Publication Lists (PubMed)

  • KITAMURA Shinya
    Assistant professor

    More

    Certification

    Board Certification by Japanese Dermatological Association

    Professional Societies

    The Japanese Dermatological Association
    Japanese Skin Cancer Society
    Japan Organization of Clinical Dermatologists

    Education and professional experience

    2011 Mar M.D., Saga University School of Medicine
    2011 Apr Junior Resident, Chitose City Hospital
    2013 Apr Senior Resident, Dermatology Dept., Hokkaido Univ. Hospital
    2013 Dec Medical staff, Dermatology Dept., Obihiro Kosei Hospital
    2014 Apr Medical staff, Dermatology Dept., Hokkaido Univ. Hospital
    2020 Mar  Ph.D., Dermatology Dept., Graduate School of Medicine, Hokkaido University
    2021 Apr  Assistant professor, Dermatology Dept., Hokkaido Univ. Hospital

    Major Publications

    1. Maeda T#, Kitamura S#, Nishihara H, Yanagi T:
      Extramammary Paget’s disease patient-derived xenografts harboring ERBB2 S310F mutation show sensitivity to HER2-targeted therapies.
      Oncogene 39; 5867-5875, 2020. # co-first author
    2. Kitamura S, Maeda T, Yanagi T:
      Vandetanib inhibits cell growth in EGFR-expressing cutaneous squamous cell carcinoma.
      Biochem Biophys Res Commun 531: 396-401, 2020.
    3. Kitamura S, Yanagi T, Maeda T, Shimizu H:
      Drp1 expression levels correlate with clinical stage in extramammary Paget’s disease.
      J Eur Acad Dermatol Venereol 34: e510-e513, 2020.
    4. Kitamura S, Yanagi T, Inamura-Takashima Y, Imafuku K, Hata H, Fujioka Y, Ohba Y, Shimizu H:
      Dermoscopic evaluation for skin grafts after surgery; neo-vascularization correlates with survival of skin grafts: a prospective study.
      J Dermatol Sci 90; 213-216, 2018.
    5. Kitamura S, Yanagi T, Imafuku K, Hata H, Shimizu H:
      Lipofuscin deposition causes the pigmentation of apocrine hidrocystoma.
      J Dermatol 45; 91-94, 2018.
    6. Kitamura S, Yanagi T, Inamura-Takashima Y, Imafuku K, Hata H, Uehara J, Ishida Y, Otsuka A, Hirata K, and Shimizu H:
      Retrospective study on the correlation between 18-fluorodeoxyglucose uptake in positron emission tomography-computer tomography and tumor volume, cytological activity as assessed with Ki-67 and GLUT-1 staining in 10 cases of Merkel cell carcinoma.
      J Eur Acad Dermatol Venereol 32, e285-e287, 2018.
    7. Kitamura S, Yanagi T, Imafuku K, Hata H, Abe R, Shimizu H:
      Drp1 regulates mitochondrial morphology and cell proliferation in cutaneous squamous cell carcinoma.
      J Dermatol Sci 88: 298-307, 2017.
    8. Kitamura S, Yanagi T, Inamura Y, Hata H, Imafuku K, Yoshino K, Shimizu H:
      Pazopanib does not bring remarkable improvement in patients with angiosarcoma.
      J Dermatol 44: 64-67, 2017.
    9. Kitamura S, Hata H, Imafuku K, Fujita Y, Shimizu H:
      Dermoscopic findings of irritated seborrheic keratosis.
      J Eur Acad Dermatol Venereol 30: e94-e96, 2016.
    10. Kitamura S, Hata H, Inamura Y, Imafuku K, Sakashita T, Hirata K, Shimizu H:
      Positron emission tomography-computed tomography can be useful in the early detection of metastases in primary mucinous carcinoma of the skin on the head and neck.
      Br J Dermatol 173: 1263-1265, 2015.

    Publication Lists (PubMed)

  • IMAFUKU Keisuke
    Assistant professor

    More

    Certification

    Board Certification by Japanese Dermatological Association

    Professional Societies

    The Japanese Dermatological Association
    The Japanese Society for Investigative Dermatology
    Japanese Organization of Clinical Dermatologists
    Japanese Society for Psoriasis Research

    Education and professional experience

    2012 Apr M.D., Hokkaido University School of Medicine
    2012 Apr Junior Resident, Kitami Red Cross Hospital
    2013 Apr Junior Resident, Hokkaido Univ. Hospital
    2014 Apr Medical staff, Dermatology Dept., Hokkaido Univ. Hospital
    2015 Apr Medical staff, Dermatology Dept., Tokyo Metropolitan Cancer and Infectious Diseases Center
    2016 Apr Medical staff, Dermatology Dept., Hokkaido Univ. Hospital
    2022 Mar Ph.D., Dermatology Dept., Graduate School of Medicine, Hokkaido University
    2022 Apr Assistant Professor, Dermatology Dept., Hokkaido Univ. Hospital

    Major Publications

    1. Imafuku K, Kamaguchi M, Natsuga K, Nakamura H, Shimizu H, Iwata H:
      Zonula occludens-1 demonstrates a unique appearance in buccal mucosa over several layers.z
      Cell Tissue Res 384: 691-702,2021.
    2. Imafuku K, Hata H, Yanagi T, Kitamura S, Inamura Y, Nishimura M, Kitamura S, Moriwaki S, Shimizu H:
      Multiple skin cancers in patients with mycosis fungoides after long-term ultraviolet phototherapy.
      Clin Exp Dermatol 5: 523-526, 2017.
    3. Imafuku K, Yoshino K, Yamaguchi K, Tsuboi Satoshi, Ohara K, Hata H:
      Comment on: ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy’
      Br J Cancer 8: e14, 2017.
    4. Imafuku K, Iwata H, Kamaguchi M, Izumi K, Natsuga K, Ujiie H, Nishie W, Shimizu H:
      Autoantibodies of non-inflammatory bullous pemphigoid hardly deplete type XVII collagen of keratinocytes.
      Exp Dermatol 12: 1171-1174, 2017.
    5. Imafuku K, Hata H, Kitamura S, Yanagi T, Shimizu H:
      Ultrasonographic findings can identify ‘pseudoprogression’ under nivolumab therapy.
      Br J Dermatol 177: 1726-1731, 2017.
    6. Imafuku K, Hata H, Yamaguchi Y, Inamura Y, Kitamura S, Yanagi T, Shimizu H:
      Modified Dufourmentel flap, easy to design and tailor to the defect.
      J Dermatol 1: 68-70, 2017.
    7. Imafuku K, Yoshino K, Ymaguchi K, Tsuboi S, Ohara K, Hata H:
      Nivolumab therapy before vemurafenib administration induces a severe skin rash.
      J Eur Acad Dermatol venereol 3: e169-171, 2017.
    8. Imafuku K, Yoshino K, Ishiwata K, Yamaguchi K, Tsuboi S, Ohara K, Hata H:
      Lymphopenia can be a useful biomarker of adverse events related to vemurafenib.
      J Eur Acad Dermatol Venereol 31: e24-26, 2017.
    9. Imafuku K, Yoshino K, Ishiwata K, Otobe S, Tsuboi S, Ohara K, Hata H:
      A single-institution study examining cutaneous and non-cutaneous melanomas treated with nivolumab.
      J Eur Acad Dermatol Venereol 30: e227-229, 2016.
    10. Imafuku K, Yoshino K, Ishiwata K, Otobe S, Tsuboi S, Ohara K, Hata H:
      Severe rash associated with vemurafenib administration following nivolumab therapy.
      J Eur Acad Dermatol Venereol 30: e84-e86, 2016.

    Publication Lists (PubMed)

Medical Staffs / Residents / Visiting Clinical Doctors
  • KENMOTSU Yasuko
  • UJIIE Inkin
  • TSUJIWAKI Masumi
  • MORITA Yusuke
  • SUGAI Tatsuro
  • HIKICHI Shiori
  • MIYAZAWA Hajime
  • ITAMOTO Sota
  • KUROSAWA Suguru
  • NAGATA Yuri
Ph.D. Course Students
  • YOSHIMOTO Norihiro
  • PEH Jin Teng
  • MAI Shoko
  • MAEDA Takuya
  • TOKUCHI Keiko
  • TAKEDA Masae
  • WENG Yu
  • SHIIYA Chihiro
  • NOHARA Takuma
  • HSU Che-yuan
  • SEO Takashi
  • KATAYAMA Sho
  • MIYAMOTO Kodai
  • KAWAMURA Takuya
Researchers
  • ZHENG Miao
Central Research Institute
  • NAKAMURA Hideki
Researching Abroad
  • WATANABE Mika
  • ITO Takamasa
  • TAKASHIMA Shota
  • MURAMATSU Ken
  • MIYAUCHI Toshinari
Laboratory Technicians
  • IKESHITA Nami
  • TANABE Mika
  • YAMASHITA Miho
Medical Secretaries
  • FRANK Mayumi
  • ISHIKAWA Chieko
Secretaries
  • OGAWA Satomi
  • KASAI Kanako
  • OSUMI Maki
On leave of absence
  • TOYONAGA Ellen
  • TAKASHIMA Yuka
Professor Emeritus
  • OHKAWARA Akira
Visiting Professors
  • NOMURA Toshifumi
  • IWATA Hiroaki
Assistant Adjunct Professors
  • KUMAKIRI Masanobu
  • SATO Hidetsugu
  • MATSUMURA Kazuko
  • SHIMIZU Satoko
  • KODAMA Kazuo
  • NAKAMURA Hiroyuki
  • ITO Kei
  • OTA Mitsuhito
  • HOSHINA Daichi
  • ANAN Takashi
  • MIZUNO Osamu
  • SUZUKI Shotaro
  • FUJITA Yasuyuki
  • FUJIMURA Yu
  • HOTTA Moeko
  • MAYA Yuka